This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Index funds provide broad diversification, predictable costs, and easy implementation, appealing to both beginners and seasoned investors.
24,105 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
In this edition of the Morning Minute, Saylor is back to buying, signaling renewed confidence in Bitcoin. We break do...
When markets wobble, patient investors can uncover excellent stocks at better prices. This guide highlights two solid...
A Detroit autoworker’s dream of winning margins meets a global market that’s increasingly dependent on China. This ar...
February brought a sharp move in Hycroft Mining stock as gold and silver prices rose and investors weighed future pro...
A new wave in AI infrastructure is building: the million-XPU data center. This article explains what it is, why it ma...
Space stocks can swing on headlines and momentum. This article explains why rocket stock popped then dropped, what dr...
A dramatic earnings miss sent EHang stocks lower, highlighting the challenges facing early-stage eVTOL developers. Th...
CVS Health is leveraging its vast network to tap into the GLP-1 weight-loss wave. This explainers-backed piece breaks...
When a CEO sells shares, investors watch closely. This piece breaks down Exponent's move by Catherine Corrigan, expla...
Investing in space-related stocks can be thrilling and risky. This article lays out two crucial things every rocket i...
Powell Industries may fly under the radar, but patient investors can uncover a potential opportunity. This guide brea...